Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive and often fatal disease that presents significant challenges for patients and clinicians. Characterized by the deposition of misfolded transthyretin protein in the heart, ATTR-CM leads to debilitating heart failure, arrhythmias
On 25 September, the Global Cardiovascular Funders Forum grant will be launching the International Research Challenge – a USD $10 million global grant.
BACKGROUND: Women experience more poststroke physical activity limitations, but sex differences in social activity participation, an important patient-reported outcome for stroke recovery, remain uncertain. METHODS:…
Exposure to high nighttime aircraft noise was tied to cardiac remodeling consistent with changes associated with increased risk for major adverse cardiac events, researchers reported.A…
BackgroundTPM3 (tropomyosin 3) is an actin‐binding protein in vascular smooth muscle cells, where posttranslational modifications critically regulate its actin affinity, influencing cardiovascular …
Dr. Swati Mehta is developing a program that will help people restore their mental health after stroke.
Steven Nissen and C. Michael Gibson discuss using bempedoic acid to reduce MACE in statin-intolerant patients with high cardiovascular risk.
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio…
Society of Vascular and Interventional Neurology Annual Meeting November 20-22, 2024 Mechanical thrombectomy is a dynamic discipline fueled by continuous innovation to refine techniques, optimize…
The health benefits of time-restricted eating go beyond weight loss and may be most prominent in patients already with cardiometabolic syndrome at baseline, a speaker…
